old and slow process of gene flow, admixture with many different populations and local differentiation. These include the expansion from isolated population nuclei in refuges following the Last Glacial Maximum, the movement of peoples related to the introduction of agriculture, and subsequent Roman and Germanic invaders, which may have influenced the distribution of genetic diversity in the territory (Amaral & Amaral, 1997) . Roman settlers strongly influenced Portuguese culture, particularly the Portuguese language, which is derived from Latin. During the 8th century Muslim Moors occupied most of the Iberian Peninsula, contributing also to admixture events observed by the presence of north African paternal lineages in the Portuguese genetic background (Adams et al., 2008; Pereira et al., 2000a) . With the establishment of the country in the year 1139, after several wars, Portugal is the oldest European nation-state. In the 15th and 16th centuries, as the result of maritime expeditions, the country established a global empire that included possessions in Africa, Asia, Oceania and South America, becoming the world's major economic, political and military power. Portugal's empire was the first and most long-lived global empire in the world, spanning almost six centuries (Russel-Wood, 1998; Jenkins & Sofos, 1996) . During the Portuguese age of discovery, two archipelagos -Madeira and Azores (Figure 1 ) -, which are currently part of the country's territory, were discovered. The Azores is composed of nine volcanic islands unevenly distributed by three geographic groups: the Eastern group with two islands -São Miguel and Santa Maria -, the Central includes five islands -Terceira, Pico, Faial, São Jorge and Graciosa -, and the Western group with Flores and Corvo. This archipelago has a total area of 2332.74 km 2 , unevenly distributed by the nine islands, varying from São Miguel, the largest, with 746.82 km 2 to Corvo, the smallest, with 17.13 km 2 . The present-day population is composed of 241,763 inhabitants (National Institute of Statistics -Portugal, 2001 Census), derived from about 27 generations. The majority of the population lives on São Miguel (54.4%). The remainder is unevenly dispersed throughout parental birthplace. As far as São Miguel is concerned, the sample consisted of 7.5mL of blood, while in the other islands only 2.7mL were collected. In order to assure individual ancestral origin, the blood collection was preferably taken from individuals whose parents were born in the same island. A thorough analysis of the parental birthplace revealed a distribution of individuals by four different groups (Table 1) . 
Parents origin Samples

No. %
Both parents were born in the same island 1373 88,13 Both parents were born in different Azores islands 70 4,49 Only one parent was born in the Azores islands 59 3,79 No parents born in the Azores islands 56 3,56 Individuals that inhabit the Azores islands 1558 100,00 Table 1 . Parental birthplace analysis of the individuals that compose the Azorean DNA bank.
A total of 1443 individuals (92.6%) presented Azorean parents. Age and sex distribution show an average age of 42 years old, ranging from 18 to 88 years, and the majority of individuals are men (71%, Figure 3 ). Considering the individuals who both parents were born in the same island (N=1373), the population representativeness varies from 0.2% (Terceira) to 7% (Corvo). The largest sample representation is observed in São Miguel with 64% ( Figure 3 ). The relation between the number of inhabitants and samples in each island
STUDY OF THE GENETIC DIVERSITY IN THE AZOREAN POPULATION
This leaflet is intended to inform you about the objectives and goal of the study entitled "Study of the genetic diversity in the Azorean population". We aim that after this inf ormation you decide free and clearly whether or not you want to participate. In the affirmative case your participation consists in donating 2.7 mL of blood to the Hospital of Divino Espírito Santo of Ponta Delgada, EPE (HDES) collected in the Health Centre of your residence . Your sample will be used to extract genetic material which will be stored at the Molecular Genetics and Pathology Unit (UGPM) of the HDES.
Why is this study being done?
The purpose of this study is to identify and quantify the genetic variation that is present in the population of the different Azorean islands , analysing t he diversity present in the genetic material (DNA).
Is my participation important?
Yes, your particip ation is very important because this study is only possible if a large number of Azorean blood samples are analyzed. You will contribute to a better understanding of the origin , nature and distribution of genetic disorders in the Azorean .
What should I do to participate?
To participate you have to donate 2,7 ml of blo od for DNA extraction . With the help of a specialized team in the Heath Centre, you will fill an anonymous record of the blood sample , providing information concerning your age, sex, birth place and your parent's birth place.
How will my personal informa tion be kept private?
After your blood sample is collected a code number will be assigned which will identify sample during this project protocol. Only the Heath Centre will have access to your name, thus guaranteeing the anonymous nature of the genetic material and corresponding personal information.
Are there any risks associated with this study? No, there are no risks associated with this study.
Are there any financial benefits in taking part in this study? No, there is no financial gratification in taking part i n this study. 
Population studies: knowing the past to predict the future
The plethora of genomic research, produced since the first draft of the human genome (Venter et al., 2001; International Human Genome Sequencing Consortium, 2001 ), led to the acknowledgment that disease related rare variants with small effects are very difficult to identify ( Figure 4 ) and that common variants implicated in complex diseases are frequently determined by GWAS. Additionally, the Human Genome Project (http://www.genome.gov/ 10001772) also contributed to the understanding of the structure and organization of the genome. Variability is observed through single nucleotide polymorphisms (SNPs), variable number of tandem repeats (VNTRs; e.g. mini and microsatellites), presence or absence of transposable elements (e.g. Alu elements) and structural alterations, which include insertions, deletions, duplications, inversions, translocations and copy number variants (CNVs). The global analysis of population neutral variation is an essential part in the comprehension of the disease related variation, since it has also been subject to evolutionary forces, such as, www.intechopen.com genetic drift, mutation, selection and migration. Altogether, the perception of our "roots" and genetic signature has several implications in society's own knowledge, in the design of future genetic studies, as well as, in the healthcare system. Fig. 4 . The frequency spectrum of human disease risk alleles includes alleles at all frequencies from rare to common, with effect sizes from high to low (from Manolio et al., 2009 ).
Diversity, ancestry and linkage disequilibrium
The comprehension of how genetic diversity is structured in the human being is not only of anthropological importance, but also of medical relevance with significant implications for human evolution, forensics, genetic diseases and pharmacogenetics (1000 Genomes Project Consortium, 2010 The International HapMap Consortium, 2010; Heard et al., 2010) . As more geographic populations are studied with high density genotype arrays it is also becoming apparent that allele frequencies for the relevant disease markers can vary widely.
For instance, what is true for Europeans may not be for Africans, such is example the Type 2 Diabetes protective allele with increased frequency in non-Africans compared to Africans (Silander et al., 2009; Kral et al., 2011) . These emerging data must be incorporated into a strategy that positions genomic medicine for a clinical role.
To grasp the genetic origins of mainland Portugal and Azorean populations studies on Ychromosome lineages Montiel et al., 2005; Beleza et al., 2006; Gonçalves et al., 2005; Fernando et al., 2005) , mitochondrial DNA (Pereira et al., 2000b; Santos et al., 2003; Santos et al., 2005; Santos et al., 2008; Santos et al., 2010) and autosomal Alu insertion polymorphisms were performed. The nonrecombining portion of the Ychromosome retains a record of the mutational events that occurred along male lineages throughout evolution (Karafet et al., 2008) . Presently, new binary polymorphisms reshaped and increased resolution of the Y-haplogroup tree; however, for comparison purposes old nomenclature was maintained. According to Pacheco et al. (2005) , the Azorean population presented nine different haplogroups, most of which are frequent in Europe ( Figure 5 ). Hapogroup J* is the second most frequent in Azores (13.4%), but it is modestly represented in mainland Portugal (6.8%). The other non European haplogroups -N3 and E3a -, which are prevalent in Asia and subSahara, respectively, have been found in Azores (0.6% and 1.2%, respectively) but not in mainland Portugal (Neto et al., 2007) . The absence of haplogroup E3a in western Iberia suggests that, despite the massive introductions of African slaves in historical times, there was little admixture between the African males and western Iberian populations (Pereira et al., 2000a) . In general, four major haplogroups -P*(xR1b8,R1a,Q3), J*, BR*(xB2b,CE,F1,H,JK) and E*(xE3) -account for the majority of the male lineages in the Azores and mainland Portugal. All studies Montiel et al., 2005; Beleza et al., 2006; Fernando et al., 2005) report that the main contributors to the genetic origin of the Azores are, as expected, the mainland Portuguese. Moreover, an important contribution of Middle eastern (HG J*) and north African (HG E*(xE3)) populations is observed in both populations. This observation is corroborated by mitochondrial DNA HVRI (hypervariable region I) analysis, where the majority of mtDNA lineages originated from the Iberian peninsula, mainly from mainland Portugal. The presence of Jews in the Azorean Central group is also supported by the mtDNA data (Santos et al., 2003) .
Without any doubt, Y-chromosome and mtDNA studies are crucial to address the origin of the population; however, a population loses mtDNA when a woman has only sons and Ychromosome DNA when a man has only daughters. As a result, these genetic markers may give less correct information on broad ancestry of most genes in a population. A full picture of the histories of populations requires studies of markers in the recombining parts of the nuclear DNA, namely the autosomes. Albeith several types of markers can be used to achieve this purpose, Alu insertion polymorphisms present some interesting advantages. These markers arose within the human population as a unique event in evolutionary history, making Alu repeats identical by descent from a common ancestor (Batzer & Deininger, 2002) . Moreover, the ancestral state, which is absence of the Alu insertion, is always known. The allele frequencies for each Alu polymorphism in Azoreans and mainland Portugal ( Table 2 . Alu insertion frequencies, heterozygosity and gene diversity for Azores and mainland Portugal. F IS represents inbreeding coefficient (from Branco et al., 2006) .
The evolution of populations is dependent on several mechanisms, such as migration, genetic drift, selection and mutation, all affecting the patterns of diversity of neutral and disease variants. Consequently, the measure of diversity of neutral markers allows the inference of how these processes are shaping the overall signature of a population and has further implications in the general diseases apportionment. Genetic diversity values, based on autosomal STR markers, for Azores (0.788; Branco et al., 2008a; Santos et al., 2009) and mainland Portugal (0.782; Perez-Lezaun et al., 2000) indicate that both populations are very diverse. Studies of HLA markers in mainland (Spinola et al., 2005a ; 3 loci) and in Azores (Spinola et al., 2005b ; 6 loci) demonstrate values of average diversity of 0.92. The results obtained for Azores (Pacheco et al., 2010) , based in 7 loci, presented a smaller value (0.83). HLA haplotype analysis showed that A*01-B*08-DRB1*03 haplotype, known to be of IndoEuropean Celtic origin, is present in Centre and North Portugal regions at relatively low frequencies of 3% and 2.2%, respectively. However, this haplotype is the most frequent in São Miguel Island (8%). According to Spínola et al. (2005b) , it's presence results from a colonizing event from people originating from the Centre of Portugal. The patterns of genetic diversity of a population have a direct influence in the linkage disequilibrium (LD) extent, which has been found to improve the knowledge of human evolution and origin, and to identify genes causing disease. Table 3 describes the number of haplotypes, gene diversity and standardized multiallelic disequilibrium coefficient (D'), based on X-linked markers for Azores and mainland Portugal populations (Branco et al., 2008b; Table 3 . Haplotype number (HN), gene diversity (GD) and standardized multiallelic disequilibrium coefficient (D') for Azorean and mainland Portugal populations (from Branco et al., 2008b) .
The Azorean Western group shows a higher genetic diversity (0.718) when compared with the other two groups. Overall, Azoreans and mainland Portuguese do not show extensive LD, as direct consequence of the large genetic diversity of these populations. These data were also corroborated by Silva et al. (2010) , based on pairwise linkage of 10 X-chromosome STRs, and Service et al. (2006) , who compared levels of LD between several European populations. Finally, both mainland Portuguese and Azoreans constitute admixed and outbred populations.
Studies of rare and common genetic diseases
Population genetic architecture can also be revealed by distribution patterns of mutations causing Mendelian disorders. Bering this in mind, the UGPM developed three main research areas, based on the Azorean healthy population. The first encompassed the analysis of mutations causing Gilbert's syndrome (GS) and hereditary haemochromatosis (HH), the second constituted the evaluation of some genetic variants predisposing to complex diseases, namely, congenital heart diseases (CHD) and thrombosis, and, finally, the third included the characterization of variants involved on drug metabolism, particularly, irinotecan and warfarin. The results from these research projects are presented and discussed in this section.
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Gilbert's syndrome
Gilbert syndrome is a mild hereditary unconjugated hyperbilirubinemia without liver dysfunction or hemolytic anemia (Matsui et al., 2010; Zhang et al., 2007) . No treatment or long-term medical attention is necessary and it is usually one of the differential diagnoses of liver or hemolytic disease. The primary cause of this syndrome is the accumulation of bilirubin -hyperbilirubinemia -, due to decreased hepatic activity levels of glucoronosyl transferase, an enzyme responsible for glucoronidation reaction ( Figure 6 ; Matsui et al., 2010) . Fig. 6 . Bilirubin uptake and processing in the liver cell. The heme initially breaks apart into biliverdin, which is rapidly reduced to bilirubin (1). Bound to albumin, bilirubin is transported from sites of production to hepatic sinusoids (2). At the sinusoidal surface of hepatocytes, bilirubin dissociates from albumin and enters hepatocytes by facilitated diffusion (3). Binding to cytosolic glutathione-S-transferases (GSTs) increases net uptake of bilirubin by inhibiting its efflux (4). Bilirubin is converted to mono-and diglucuronide by the action of UGT1A1, which catalyses the transfer of the glucuronic acid moiety from UDPglucuronic acid (UDPGA) to bilirubin (5). Bilirubin glucuronides are actively transported into bile against a concentration gradient by the ATP-utilizing pump MRP2 (6; Figure from http://www.natap.org/2011/EASL/EASL_83.htm).
Bilirubin has been shown to inhibit DNA synthesis, uncouple oxidative phosphorylation, and inhibit ATPase activity in brain mitochondria (Strassburg, 2010) . It also inhibits a variety of different classes of enzymes including dehydrogenases, electron transport proteins, hydrolases, enzymes of RNA synthesis, protein synthesis and carbohydrate metabolism. All toxic effects of bilirubin are reversed by binding to albumin. In fact,
www.intechopen.com albumin plays a vital role in the distribution of bilirubin in the body by keeping the compound in solution and transporting it from sites of production (primarily bone marrow and spleen) to the liver (Strassburg, 2010) . GS is associated with a dinucleotide polymorphism in the TATA box promoter of the UDP glucuronosyltransferase 1 (UGT1A1) gene, more precisely the UGT1A1*28 allele (Costa, 2006) . In São Miguel Island a group of 67 suspected GS patients and 469 unrelated healthy blood donors were studied  A molecular study based in a cohort of 120 Portuguese patients with the clinical diagnosis of Gilbert syndrome demonstrated that 110 individuals were homozygous for the UGT1A1*28 allele (*28/*28), and one patient was a compound heterozygote for two different insertions *28/*37. The remaining 9 patients were heterozygous, *1/*28 . The analysis of the control group allowed the identification of alleles characteristic of African populations, *36 (0.2%) and *37 (0.1%), which corroborates previous data on the Azorean and mainland Portuguese genetic background.
Hereditary hemachromatosis
Hereditary haemochromatosis (HH) is an inherited disorder characterized by accumulation of iron. The phenotypic condition was uncommon and typically diagnosed only when significant complications had ensued. The transmission mode is autosomal recessive and the disease manifests more commonly in males than in females, where natural iron losses are greater (Pietrangelo, 2004; Griffiths, 2007) . In HH, gradual deposition of iron occurs in the liver and in a number of other tissues including the pancreas, joints, skin and heart. Disease manifestations include hepatic fibrosis, diabetes mellitus, arthropathy, pigmentation, cardiomyopathy and hypogonadotrophic hypogonadism. Fatigue and arthralgia are www.intechopen.com common early symptoms and painful arthropathy is a considerable cause of morbidity. However, it is iron toxicity within the liver which increases mortality in patients with HH. Cirrhosis of the liver is associated with significantly reduced survival and there is a 200-fold increased risk of hepatocellular carcinoma (Pietrangelo, 2004; Griffiths, 2007; Swinkels et al., 2006) . The HFE gene encodes an HLA-A class 1-like protein and is located on 6p21.3, 4 megabases (Mb) telomeric to the human leukocyte antigen region (HLA). Two HFE mutations -C282Y (845 G>A) and H63D (187 C>G) -are significantly correlated with HH (Feder et al., 1996) . The majority (60% to 90%) of clinically diagnosed probands are homozygous for C282Y, and 5% are compound heterozygous for C282Y and H63D. The C282Y allele frequency in São Miguel population is 5.01%, a similar frequency (5. 8%; de Fez et al., 2005; Gomes et al., 2007) to the obtained in the north of mainland Portugal, but statistically different from that observed in the south populations (0.9%; Cardoso et al., 2001 ). Contrary to this C282Y decreasing gradient, the H63D presents an even country distribution (Figure 10) , with values of 17.88% and 20.36% for mainland and São Miguel Island, respectively. Because C282Y mutation seems to have originated by chance on a HLA-A*03-B*07 haplotype in an individual from northwestern Europe and early spread, by Celts or Vikings (Milman & Pedersen, 2003; Distante et al., 2004) , in many countries including Portugal, the background of this mutation was assessed in São Miguel islanders (Gomes et al., 2007) . Four non-ancestral HLA haplotypes were associated with C282Y: A*01-B*35, A*02-B*44, A*02-B*55 and A*24-B*15, contrary to mainland, where the C282Y occurred mainly on the ancestral haplotype HLA-A*03-B*07 (Cruz et al., 2006) . In addition, the C282Y mutation was also identified in two HLA A*03 bearing: A*03-B*27 and A*03-B*50. These results evidence that C282Y mutation was introduced in the Azorean population by individuals with genetic background other than Celts or Vikings. 
HFE -C282Y HFE -H63D
Congenital heart disease
The evaluation of genetic variants predisposing to complex diseases in Azores began with the characterization congenital heart diseases (CHD). Congenital malformations of the heart and great vessels are among the most frequent of all clinically significant birth defects, with a major contribution to paediatric morbidity, mortality and healthcare costs. Fig. 11 . Three major classes of developmental defects are indicated: defects in atrial septation, in ventricular or atrioventricular septation, and in the great vessels. The types of congenital heart disease that occur within each class are indicated, with the associated mutated genes listed. AC, aortic coarctation; AS, aortic stenosis; ASD, atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; DORV, double outlet right ventricle; Ebstein's, Ebstein's anomaly of the tricuspid valve; HLHS, hypoplastic left heart syndrome; HRHS, hypoplastic right heart; IAA, interrupted aortic arch; MA, mitral atresia; MS, mitral stenosis; PDA, patent ductus arteriosus; PS, pulmonary artery stenosis; PTA, persistent truncus arteriosus; TA, tricuspid atresia; TAPVR, total anomalous pulmonary venous return; TGA, transposition of the great arteries; TOF, tetralogy of Fallot; VSD, ventricular septal defect (From Bruneau, 2008) .
Population based epidemiologic studies indicate a prevalence of CHD ranging from 3.23 to 12.23 per 1000 live births (Dolk et al., 2011; Bruneau, 2008; Engelfriet et al., 2005) . This wide variation in the reported values is mainly due to the difference in the methodologies used, but a number of other factors, such as consanguinity, ethnic background, environmental pollutants and access to healthcare also contribute to this variation (Becker et al., 2001; Nabulsi et al. 2003; Botto et al., 2001 Considering that half of the São Miguel population lives in small rural localities (range from 309 -7407 inhabitants for Lomba de São Pedro and Rabo de Peixe, respectively) and the internal migration is reduced, aspects that increase endogamy and inbreeding, a structured family questionnaire to the parents with CHD children was performed. The questionnaire included i) questions for CHD risk factors -maternal diabetes mellitus, alcohol and drug abuse by the mother during pregnancy, viral infections of the fetus and genetic conditions -, ii) queries concerning the number of family members affected with CHD and parental consanguinity, and iii) a detailed family history to construct the ascending genealogy until the 3th generation. Results revealed a relatively high number of multiplex families (44; www.intechopen.com 40.37%, Table 6 ) and a significantly high value of consanguinity (9.17%). Half of the consanguineous families (5 out of 109 total families) are multiplex. In addition, 36 out of 44 multiplex families are endogamous (81.8%; Table 7 ). The data suggest that genetic factors may be responsible for the development of CHD in São Miguel Island. Familial aggregation, which is of great interest for understanding the genes involved in these complex pathologies, is evident.
Parameters
Families (N=109)
No. % 
Thrombosis
In February 2007, the National Geographic Portugal magazine published a special issue dedicated to cardiovascular diseases. Based on the Euro Heart Survey 2006, the number of deaths per 100,000 inhabitants in 2004, due to CVD, places Portugal with higher values (390) compared with south-western European countries like Spain (290), France (262) and Belgium (364). In a similar analysis, performed within Portugal regions, the Azores archipelago clearly stands out with the highest value (116.9), followed by Lisbon (84.8).
Family based investigation tends to have biased relative risk estimation, because oversampling of affected individuals is normally present. Therefore, the genetic characterization of disease variants in the general population is important to correct this potential bias. Since thrombosis is a common cause of CVD, analysed four polymorphisms in three thrombotic risk genes -F5 (G1691A), F2 (G20210A) and MTHFR (C677T, A1298C), in 469 healthy blood donors from São Miguel Island. Figure 12 shows allele frequencies in Caucasian populations, including São Miguel, for the above mentioned polymorphisms.
Comparison of allele frequencies for thrombotic risk factors between São Miguel and mainland Portugal (Mansilha et al., 2006) revealed statistically significant differences ( 2 , p<0.001; Table 9 ) for F5 -1691A, justifying the need to perform regional biomedical research to ultimately benefit the patient. Table 9 . Comparison between thrombotic genetic risk variants frequency between Azoreans and mainland Portugal.
Twenty-two different genetic profiles for F5, F2 and MTHFR (order in genotype profile) were observed in São Miguel's population ( Figure 13 ). The frequency of individuals who present a wild-type genotype for all polymorphisms (GG GG CC AA; 11.7%) was almost half of the major profile (GG GG CT AA; 22.4%), differing in heterozygosity for MTHFR 677CT. No heterozygous or homozygous profiles for all four variants were observed. Taken together, 12.4% (58 out of 469) of São Miguel islanders have increased genetic predisposition to thrombosis. No general population profile analysis for mainland Portugal is reported in the literature, and, consequently, no comparison was performed. These results are corroborated by further CVD studies, where 2 genomic regions associated with CVD risk, USF1 and 9p21 were evaluated . Preliminary results, based on haplotype inference, showed that USF1 "CCGCC" (0.288) and "CTGCT" (0.346) are the two most frequent haplotypes in Azoreans, which, according to Komulainen et al. (2006) , correspond to the protective and high risk haplotype in females, respectively. In 9p21
www.intechopen.com region, the risk haplotype "TGGGCGCGC", associated with CHD in Europeans (Silander et al., 2009) , is the most frequent (0.414). Analysis of homozygosity patterns for risk genotypes showed similar frequencies for USF1 (12.4%) and 9p21 region (14.7%), indicating that, despite recombination, homozygosity must be taken in consideration when performing risk profile studies. Collectively, the data suggest that there is a considerable genetic risk for CVD in Azoreans, evidencing the need to carry out regional genetic studies with the aim to improve and complement health strategies adopted by the decision makers of each country. Further genetic studies on CVD are on-going.
Pharmacogenetics of irinotecan and warfarin
In the last 50 years, fundamental developments in pharmacology and genetics led to important improvements in personalized medicine based on pharmacogenetics and pharmacogenomics. Pharmacogenomics uses a whole genome approach to investigate or predict drug responses, or to relate the application of these technologies to drug discovery, while pharmacogenetics is the study of the clinically relevant inherited differences in drug response that can be in part explained by genetic variations. Pharmacogenetic analysis contributes to reduce adverse drug reactions (ADRs) or to maximize drug efficiency.
Variants involved in drug metabolism of two commonly prescribed drugs, irinotecan and warfarin, were studied in Azoreans and mainland Portugal.
Pharmacogenetics of irinotecan
Irinotecan, an antineoplastic-prodrug, is widely used for the treatment of colorectal, lung and other cancers. The most clinically significant adverse events for patients receiving irinotecan-based therapy are diarrhea, neutropenia, nausea, vomiting and alopecia (Kehrer et al., 2001; Marques & Ikediobi, 2010; Lankisch et al., 2008; Fujiwara & Minami, 2010) . Irinotecan can induce both early and late forms of diarrhea and requires dose adjustment based on severity of diarrhea. Also, sepsis related death following severe neutropenia has been reported in irinotecan treated patients. The active metabolite SN-38 is responsible for the pharmacological and toxic effect of irinotecan. SN-38, is a topoisomerase I inhibitor generated by hydrolysis of irinotecan by carboxylesterases (Figure 14) . SN-38 is subsequently glucuronidated by uridine diphosphate glucuronosyltransferase 1As (UGT1As) to form an inactive metabolite, SN-38G (Marques & Ikediobi, 2010; Fujiwara & Minami, 2010) . The human UDP-glucuronosyltransferase 1A gene locus is organized to generate enzymes, which share a carboxyterminal portion and are unique at their aminoterminal variable region. Expression is tissue-specific and overlapping substrate specificities include a broad spectrum of endogenous and xenobiotic compounds, as well as many therapeutic drugs targeted for detoxification and elimination by glucuronidation. The absence of glucuronidation leads to fatal hyperbilirubinemia (Marsh & Hoskins, 2010; Zhang et al., 2007) . Genetic variants and haplotypes have been identified as risk factors for unwanted drug effects of cancer treatment with irinotecan. Since variants in UGT1A1, UGT1A6 and UGT1A7 are related to irinotecan toxicity, these were studied in 469 individuals from São Miguel Island by Pacheco et al. (2009) . Haplotype analysis revealed that H3 (Table 10) , which includes all low activity allelic variants of the three UGT isoforms, accounts for 23.5% of the population, suggesting that those individuals have reduced glucuronidation activity due to the combination of UGT1A1*28, UGT1A6*2 and UGT1A7*3 alleles. 
Pharmacogenetics of warfarin
Warfarin is one of the most widely used anticoagulant drug, which requires a thorough riskbenefit analysis since the dose prescribed should avoid hemorrhagic complications and achieves suppression of thrombosis (Wadelius & Pirmohamed, 2007; You 2011; Limdi & Veenstra, 2008) . The administrated drug is a racemic mixture of S-and R-enantiomers, having S-the majority of the therapeutic effect ( Figure 15 ). Warfarin pharmacogenetic studies demonstrated that variants in the CYP2C9 (Cytochrome P450 2C9) and VKORC1 (Vitamin K epoxide reductase complex subunit 1) genes account for approximately 50-60% of drug dosing variability (Finkelman et al., 2011) . The remaining variability can be explained by clinical and environmental factors (age, sex, diet, concomitant drugs, body mass index), which in conjunction with genetics are used, in warfarin dosing algorithms, as an advice for the best dose prescription. Cytochrome P450 2C9 is the major enzyme responsible for metabolising the active S-enantiomer. Although there are many polymorphisms in CYP2C9, the most clinically relevant variants are: CYP2C9*1 (Arg144/Ile359, wild-type), CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu). These last two are associated with decreased metabolic efficiency of the CYP2C9 enzyme and increased risk of bleeding when administrated initial dosages of warfarin (Yasar et al., 1999) . Considering VKCORC1, a G>A variation at position 1639 in the gene's promoter region results in decreased mRNA transcription and increased sensitivity to warfarin inhibition of hepatic synthesis of functional vitamin K-dependent coagulation factors. Rieder et al. (2005) studied VKORC1 polymorphisms and classified individuals according to warfarin dose requirements into distinct groups: high (GG), intermediate (GA) and low (AA). Recently, the U.S. Food and Drug Administration (FDA) added to the warfarin product label dosing recommendations stratified by combined CYP2C9 and VKORC1 genotypes (http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm08337 8.htm). Comparison of separate genotypes for CYP2C9 and VKORC1 between mainland Portugal (Jorge et al., 2010) and the Azores (Pereirinha et al., 2009, personal communication) populations revealed no significant differences (Table 11 ). In the Azores population no individuals with CYP2C9-*3*3 genotype were identified, however a higher frequency of CYP2C9-*2*3 was observed when compared to mainland. The joint analysis of CYP2C9 and VKORC1, in Azoreans, showed that around 12% of individuals need low doses of warfarin, if treatment is started ( 3.5 1.1 *1*1-AA 6.4 NA *3/*3 0 1.1 *1*2-GA 13.5 NA *1*3-GA 4.1 NA *2*2-GG 1.8 NA *2*3-GG 1.8 NA *1*2-AA 4.7 NA *1*3-AA 1.8 NA *2*2-AA 0.6 NA *2*2-GA 2.9 NA *2*3-GA 1.8 NA Table 11 . Genotype frequencies of CYP2C9 and VKORC1 variants in Azores (N=170) and mainland Portugal (N=91) populations. NA-not applicable; no joint analysis of both genes has been described for mainland Portugal populations. Blue characters represent individuals who would require low doses of warfarin.
Overall, irinotecan and warfarin studies demonstrated that the Azores population shows significant differences on allele frequencies of pharmacogenetic variants, which must be taken in consideration when treating patients. These results have a high impact on the physicians' decisions in managing patient's treatment.
Conclusion
Genomic medicine, which uses the individual information to provide better healthcare, has been considerably developed since the Human Genome Project. One of its current challenges is the identification of risk alleles for multifactorial diseases and the study of their frequency in different populations. In summary, both the Azores and mainland Portugal populations are outbred with high genetic diversity, relative gene flow among its individuals, and without extensive LD. Nevertheless, the islanders have a particular genetic makeup evidenced by the African and Asian traits, and by the differences in terms of common diseases apportionment compared to mainland. Biomedical investigation has been www.intechopen.com the driving force in improving practices in patient care, based on new drugs, diagnostic methods, medical instruments and services. The genetic research performed in the Azorean population allowed the implementation of molecular diagnosis in the main Hospital of the archipelago, as well as a faster and most costly effective response to clinicians, benefiting the patient and, ultimately, the Azorean Health System.
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